Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers

Eur Heart J. 2023 Jul 1;44(25):2292-2304. doi: 10.1093/eurheartj/ehad275.

Authors

Lale Tokgozoglu¹, David A Morrow², Stephen J Nicholls³

Affiliations

¹ Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
² TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
³ Victorian Heart Institute, Monash University, Melbourne, Australia.

Abstract

Graphical Abstract

Advantages of tailoring lipid lowering therapy with biomarkers versus imaging.

Keywords: CT angiography; Hs-CRP; Lipids; Troponin; biomarkers; calcium score; imaging; risk assesment.

MeSH terms

Biomarkers
C-Reactive Protein*
Humans
Lipids*

Substances

Biomarkers
C-Reactive Protein
Lipids